Prescribing Information
Download Prescribing Information

17 PATIENT COUNSELING INFORMATION

17 PATIENT COUNSELING INFORMATION

Inform patients, caregivers or home healthcare providers of the following risks of Potassium Phosphates Injection:

Serious Cardiac Adverse Reactions with Undiluted, Bolus or Rapid Intravenous Administration [see Warnings and Precautions (5.1)]
Pulmonary Embolism due to Pulmonary Vascular Precipitates [see Warnings and Precautions (5.2)]
Hyperkalemia [see Warnings and Precautions (5.3)]
Hyperphosphatemia and Hypocalcemia [see Warnings and Precautions (5.4)]
Aluminum toxicity [see Warnings and Precautions (5.5)]
Hypomagnesemia [see Warnings and Precautions (5.6)]
Vein Damage and Thrombosis [see Warnings and Precautions (5.7)]

For Medical Information about [Potassium Phosphates Injection], please visit www.pfizermedinfo.com or call 1-800-438-1985.

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

Logo

LAB-1555-1.0

Additional Resources

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.

Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.

Available 9AM-5PM ET Monday to Friday; excluding holidays.

 

Submit a medical question for a Pfizer medicine or a vaccine. 

The submission will be reviewed during our standard business hours.

To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information: 
Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.